New Results

Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19

Douglas Ferreira Sales-Medina, Ludmila Rodrigues Pinto Ferreira, Lavínia M. D. Romera, Karolina Ribeiro Gonçalves, Rafael V. C. Guido, Gilles Courtemanche, Marcos S. Buckeridge, Édison L. Durigon, Carolina B. Moraes, Lucio H. Freitas-Junior
doi: https://doi.org/10.1101/2020.07.09.196337

Article usage

Article usage: July 2020 to March 2023

AbstractFullPdf
Jul 202037882961005
Aug 202055281202
Sep 20203596999
Oct 2020945129194
Nov 20203397390
Dec 20203585689
Jan 202129764149
Feb 20211583978
Mar 20212396191
Apr 202120657106
May 202123842103
Jun 20211866976
Jul 20211415386
Aug 20211152653
Sep 20211302252
Oct 20211032962
Nov 2021752040
Dec 202167941
Jan 202269929
Feb 2022711525
Mar 2022812036
Apr 2022722533
May 2022741223
Jun 2022551325
Jul 2022391228
Aug 2022521119
Sep 202262916
Oct 202253824
Nov 202242517
Dec 202228919
Jan 202324716
Feb 202343718
Mar 202339129
Back to top
Posted July 13, 2020.
Download PDF

Supplementary Material

Email
Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19
Douglas Ferreira Sales-Medina, Ludmila Rodrigues Pinto Ferreira, Lavínia M. D. Romera, Karolina Ribeiro Gonçalves, Rafael V. C. Guido, Gilles Courtemanche, Marcos S. Buckeridge, Édison L. Durigon, Carolina B. Moraes, Lucio H. Freitas-Junior
bioRxiv 2020.07.09.196337; doi: https://doi.org/10.1101/2020.07.09.196337
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area